The Biden Administration on Thursday declared the monkeypox outbreak a public health emergency, a move intended to dramatically ramp up the fight against the spread of the virus.
“We’re prepared to take our response to the next level in addressing this virus, and we urge every American to take monkeypox seriously and to take responsibility to help us tackle this virus,” U.S. Department of Health and Human Services Secretary Xavier Becerra said during a media briefing on Thursday.
RELATED: WHO Declares Monkeypox a Global Health Emergency
Featured on BlackDoctor
The number of reported monkeypox cases has grown to just over 6,600 in the United States, up from less than 5,000 a week ago, Becerra said. The viral disease varies in severity but is rarely fatal and typically requires close physical contact for transmission. In the United States, the vast majority of cases have occurred among men who have sex with men.
RELATED: Monkeypox On The Rise In The LBGTQ Community, Here’s How To Stay Safe
The new declaration is expected to increase public awareness and education around monkeypox, give public health officials greater flexibility in deploying manpower and resources, and increase testing and data-tracking of cases, according to Dr. Rochelle Walensky, director of the U.S. Centers for Disease Control and Prevention.
The emergency declaration also has prompted the U.S. Food and Drug Administration to seriously weigh a “dose-sparing” approach for Jynneos, the only vaccine approved to protect against monkeypox, FDA Commissioner Dr. Robert Califf announced at Thursday’s briefing.
RELATED: What Is Monkeypox, and How Worried Should Americans Be?
“We’re considering an approach for the current doses of Jynneos that would allow health care providers to use an existing one-dose vial of the vaccine to administer a total of up to five separate doses,” Califf says, noting that the “goal has always been to vaccinate as many people as possible.”
The U.S. government has delivered more than 600,000 Jynneos doses to locales in the midst of monkeypox outbreaks, Becerra says.
But estimates suggest there are as many as 1.7 million people at the highest risk for contracting monkeypox right now, Walensky adds.
These include people living with HIV and gay and bisexual men, who constitute the “population we have been most focused on in terms of vaccination,” Walensky shares.
Under dose-sparing, doctors would perform a shallow injection between the layers of the skin – an intradermal shot — rather than the usual subcutaneous injection that reaches beneath the skin, Califf notes.
“There are some advantages to intradermal administration, including an improved
immune response to the vaccine,” Califf says, promising that the FDA will make a final decision on the move “probably within the next few days.”
RELATED: “Unbearable”: 3 Patients Share What It’s Like To Have Monkeypox
Such a move would require Becerra to make a second emergency declaration that would allow federal officials to expedite potential treatments and vaccines without going through full-fledged federal reviews, Califf notes.
The World Health Organization has declared monkeypox a public health emergency of international concern, its highest-level warning. Outbreaks have been confirmed in about 70 countries where the virus has not historically spread.
According to WHO tracking data, monkeypox has now spread to about 26,000 people worldwide outside of Africa, where it has long been endemic. It is so far not linked to any deaths in the United States.
The U.S. declaration is expected to provide “access to resources and flexibilities, enabling personnel to deploy to the outbreak and potentially increase access to care to people who need it most,” Walensky says.
Officials also hope the declaration will put pressure on local jurisdictions to expand data sharing with the CDC, “so that we can have comprehensive and timely data available to inform public health decisions,” Walensky adds.
RELATED: The CDC is Monitoring new Monkeypox Cases: What is it and Should You Be Worried
Walensky notes that 51 U.S. jurisdictions already have agreed to share data on monkeypox cases and vaccine administration.
“The public health emergency may provide the justification that the remaining jurisdictions need in order to sign their agreement,” Walensky says.
The more than 602,000 doses of Jynneos that have been shipped to states and jurisdictions represents “an increase of 266,000 since just last week,” HHS Assistant Secretary for Preparedness and Response Dawn O’Connell said at the briefing.
The administration also is taking orders for another 786,000 doses and started shipping them earlier this week, O’Connell adds.
“We plan to open the next round of ordering on August 15, and as an important reminder, states and jurisdictions that have used 90% or more of their current allocation will be allowed to order additional doses sooner than August 15,” O’Connell says.
RELATED: Everything You Need to Know About Monkeypox and the Vaccine
The CDC recommends that you get vaccinated within 4 days from the date of exposure for the best chance to prevent onset of the disease if:
If you’re at risk for monkeypox or if you’ve been exposed to someone who tested positive, tell your doctor. He or she can give you a vaccine if you’re eligible for one.
RELATED: What Should You do if You’re Experiencing Monkeypox Symptoms?
If you’re under 18, your doctor will have to consult with the CDC before they can give you a vaccine.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
